Protocol - Lung Function - Lung Volume

Description

The American Thoracic Society (ATS) and the European Respiratory Society (ERS) Task Force recommendations for standardisation of the measurement of lung volume testing outline how to obtain measurement of functional residual capacity (FRC) using body plethysmography, nitrogen washout, helium dilution, and imaging techniques. In addition, this source contains details regarding the assessment of total lung capacity (TLC), vital capacity (VC), reserve volume (RV), expiratory reserve volume (ERV), and inspiratory capacity (IC).

These recommendations for standardization of the measurement of lung volume testing are part of a series of recommendations by the ATS/ERS Task Force for the standardization of lung function testing, which can be found on the ATS website at www.thoracic.org/statements/pulmonary-function.php. Detailed information regarding patient preparation is included in the general considerations document for lung function testing in this series.

Specific Instructions

A comprehensive evaluation of lung function requires investigation of various aspects of the lung, such as lung volumes and diffusion capacity. Hence, the American Thoracic Society (ATS) and the European Respiratory Society (ERS) Task Force have published a series of documents regarding pulmonary function testing. The Sickle Cell Disease: Cardiovascular, Pulmonary, and Renal Working Group recommends researchers access the ATS website (www.thoracic.org/) to view other documents in this series that may apply to their area of research.

Additionally, although there are various methods to measure functional residual capacity (FRC), the Working Group views body plethysmography as the most accurate, particularly when airflow obstruction is a possible underlying condition.

Availability

Available

Download PDF

Protocol

Lung Function Testing: Measurement of Lung Volume

The American Thoracic Society (ATS) and the European Respiratory Society (ERS) Task Force recommendations for standardisation of the measurement of lung volumes can be found here as well as on the ATS website here.

Personnel and Training Required

Certified respiratory therapist

Equipment Needs

Equipment needed for the calculation of lung volumes are outlined in the American Thoracic Society (ATS) and the European Respiratory Society (ERS) Task Force recommendations for standardisation of the measurement of lung volumes can be found here as well as on the ATS website here.

Requirements

Requirement Category	Required
Major equipment	Yes
Specialized training	Yes
Specialized requirements for biospecimen collection	No
Average time of greater than 15 minutes in an unaffected individual	No

Mode of Administration

Clinical assessment

Lifestage

Child, Adolescent, Adult, Senior, Pregnancy

Participants

Individuals age 8 years old and older.

Selection Rationale

The Sickle Cell Disease Cardiovascular, Pulmonary, and Renal Working Group recommends the American Thoracic Society (ATS) and the European Respiratory Society (ERS) Task Force 2005 recommendations for standardisation of the measurement of lung volumes because this document integrates and consolidates the task force recommendations and the recommendations from various National Heart, Lung, and Blood Institute (NHLBI) workshops.

Language

English

Standards

Standard	Name	ID	Source
Human Phenotype Ontology	Restrictive ventilatory defect	HP:0002091	HPO
caDSR Form	PhenX PX810401 - Lung Function Lung Volume	6252184	caDSR Form

Derived Variables

None

Process and Review

Not applicable.

Protocol Name from Source

Wanger, J. et al. Standardization of the measurement of lung volumes. EUR RESPIR J, 2005

Source

Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D., MacIntyre, N., McKay, R., Miller, M. R., Navajas, D., Pellegrino, R., & Viegi, G. (2005). Standardisation of the measurement of lung volumes. European Respiratory Journal, 26, 511-522. doi: 10.1183/09031936.05.00035005

General References

Arteta, M., Campbell, A., Nouraie, M., Rana, S., Onyekwere, O. C., Ensing, G., Sable, C., Dham, N., Darbari, D., Luchtman-Jones, L., Kato, G. J., Gladwin, M. T., Castro, O. L., Minniti, C. P., & Gordeuk, V. R. (2014). Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia. Journal of Pediatric Hematology/Oncology, 36(3), 185-189.

Lunt, A., Desai, S. R., Wells, A. U., Hansell, D. M., Mushemi, S., Melikian, N., Shah, A. M., Thein, S. L., & Greenough, A. (2014). Pulmonary function, CT and echocardiographic abnormalities in sickle cell disease, Thorax 69(8), 746-751.

Protocol ID

810401

Variables

Export Variables

Variable Name	Variable ID	Variable Description	dbGaP Mapping
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_Calibration
	PX810401390105	If body plethysmography method is used to more measure FRC, was the mouth pressure transducer and plethysmograph signal calibrated within the past 24 hours? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_Calibration_Controls
	PX810401390106	If body plethysmography method is used to more measure FRC, at least once a month or whenever plethysmographic errors are suspected, was the plethysmograph recalibrated with two reference subjects (biological controls)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_ConstantPressure
	PX810401390301	If volume-displacement plethysmograph, what more is the volume within the constant-pressure chambler? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_ConstantPressure_Airflow
	PX810401390101	If flow plethysmograph, what is the airflow more rate in and out of the constant-pressure chamber? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_ConstantVolume
	PX810401390201	If variable-pressure plethysmograph, what is more the pressure within the constant-volume chamber? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_Frc
	PX810401390104	If body plethysmography method is used to more measure FRC, what is the reported FRC value? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_Measurement_Technique
	PX810401390103	If body plethysmography method is used to more measure FRC, does the measurement technique adhere to the following steps? 1) Equipment should be turned on and allowed an adequate time to warm up; 2) Equipment is set up for testing, including calibration, show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_Transducer
	PX810401390102	If body plethysmography method is used to more measure FRC, is the transducer capable of measure mouth pressure greater than +/- 5kPa? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_BodyPleth_Type
	PX810401390000	If body plethysmography method is used to more measure FRC, which type of plethysmograph is used to track changes in thoracic volume? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Current_BarometricPressure
	PX810401150000	What is the current barometric pressure?	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_Current_Temperature
	PX810401140000	What is the current ambient temperature?	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_Current_Time
	PX810401160000	What is the current time?	N/A
PX810401_Standardisation_LungVolumeMeasurement_Equipment_Closed_Circuit
	PX810401230000	Since the previous subject, if a more closed-circuit technique was used, were volume-based spirometers flushed with room air at least five times over the entire volume range? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Equipment_OpenCircuit_Mouthpiece
	PX810401250000	Since the previous subject, if an more open-circuit technique was used, were volume- and flow-based spirometers used without inspiration from the measuring system had their outhpieces replaced/sterilized? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Equipment_OpenCircuit_Replacement
	PX810401240000	Since the previous subject, if an more open-circuit technique was used and the subject only expires into the spirometer, was the portion of the circuit which rebreathing occurs properly decontaminated? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Equipment_Reusable_Components
	PX810401220000	Has reusable equipment (such as mouthpieces, more breathing tubes, valves and manifolds or any other equipment showing visible condensation from expired air) been disinfected/sterilized? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_FirstMethod_Erv
	PX810401370202	If first method, what is the reported value more for the (technically satisfactory) expiratory reserve volume (ERV)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_FirstMethod_Frc
	PX810401370201	If first method, what is the reported value more for the functional residual capacity (mean of technically satisfactory FRC measurements)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_FirstMethod_Ivc
	PX810401370203	If first method, what is the reported value more for the (technically satisfactory) inspiratory vital capacity (IVC)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Analyzer_Flow
	PX810401410900	If helium dilution method is used to measure more FRC, does the helium analyzer allow a flow of >=200 mL/min? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Analyzer_Range
	PX810401410600	If helium dilution method is used to measure more FRC, does the helium analyzer have a range of ~0-10% helium, a resolution of <= 0.01% helium over the entire range, and a 95% response time of <15seconds to a 2% step change in helium concentration? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Analyzer_Stability
	PX810401410700	If helium dilution method is used to measure more FRC, is the meter stable with a drift of <= 0.02% for measurement periods up to 10 minutes? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Analyzer_Type
	PX810401410400	If helium dilution method is used to measure more FRC, what type of analyzer is being used? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Analyzer_TypeOther
	PX810401410500	If helium dilution method is used to measure more FRC, what type of analyzer is being used? Other show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_CalibrationStep
	PX810401410200	If helium dilution method is used to measure more FRC, before measurements are taken, was enough 100% helium added to the system where the helium reading was ~10%? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Calibration_Control
	PX810401411800	If helium dilution method is used to measure more FRC, was testing of biological controls performed at least once in the past month? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_CarbonDioxide
	PX810401411000	If helium dilution method is used to measure more FRC, is the breathing-circuit CO2 levels during testing below 0.5%? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_DeadSpace
	PX810401411300	If helium dilution method is used to measure more FRC, does the breathing valve and mouthpiece have a combined dead space <100mL? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Flow
	PX810401410300	If helium dilution method is used to measure more FRC, does the device have a flow of ~50 L/min? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Leak_Check
	PX810401411600	If helium dilution method is used to measure more FRC, for systems that can be pressurized, were leaks checked for at least once in the past 24 hours and/or after every tubing or canister changes? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Measurement_Technique
	PX810401411400	If helium dilution method is used to measure more FRC, does the measurement technique adhere to the following steps? 1) Equipment is turned on and allowed an adequate warm-up time, with calibration as instructed by manufacturer; 2) The equipment should be show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Oxygen_Recalibration
	PX810401410800	If helium dilution method is used to measure more FRC, for systems in which O2 concentration changes substantially, was the helium analyzer recalibrated over the range of O2 concentrations encountered? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Quality_Control
	PX810401411500	If helium dilution method is used to measure more FRC, before the subject was tested, were the following items checked? Water level of water-sealed spirometer; status of all CO2 and water absorbers; operation of the circuit fan; baseline stability of heli show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Spirometer_QualityControl
	PX810401410100	If helium dilution method is used to measure more FRC, is the capacity of the spirometer at least 7 liters and is the device equipped with a mixing fan, CO2 absorber, O2 and helium supply, a gas inlet and outlet, and a water vapour absorber in the line to show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Stability_Temperature
	PX810401411700	If helium dilution method is used to measure more FRC, was the stability (<0.02% drift in 10 min) and temperature of the helium meter checked at least once in the past week? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Temperature
	PX810401411100	If helium dilution method is used to measure more FRC, what is the temperature of the gas in the breathing circuit? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Helium_Temperature_Sensor
	PX810401411200	If helium dilution method is used to measure more FRC, does the temperature sensor have an accuracy of better than 0.5 degrees Celsius over the range of 12-30 degrees Celsius and have a 90% response time of <30 seconds to a 5 degree Celsius step change of show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Imaging_Technique
	PX810401420200	If the subject has limited ability to more cooperate, which imaging technique method will be used to measure his/her lung volume? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Imaging_Technique_Other
	PX810401420300	If the subject has limited ability to more cooperate, which imaging technique method will be used to measure his/her lung volume? Other show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Inline_Filtered
	PX810401280000	If in-line filters are being used, does the more measuring system meet the minimum recommendations for accuracy, precision (reproducibility), flow resistance, and back pressure with the filter installed? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_MethodOf_Measurement
	PX810401370100	Which method from lung volume measurement is more being used? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Method_Frc
	PX810401380000	Which method is used for measuring forced more residual capacity (FRC)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Myocardial_Infarction
	PX810401020000	Has the subject suffered from myocardial more infarction within the last month? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_BreathingValve
	PX810401400400	If nitrogen washout method is used to more measure FRC, does the breathing valve for switching the patient from breathing room air to pure oxygen have a dead space of less than 100mL for adults and <2mL/kg in smaller children? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Calibration
	PX810401400200	If nitrogen washout method is used to more measure FRC, were pneumotachographs and other flow-measuring devices calibrated within the last 24 hours by discharging a 3-liter syringe at least 3 times giving a flow range of 0-6L/s? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Calibration_Controls
	PX810401400900	If nitrogen washout method is used to more measure FRC, was the performance of the device tested with biological controls at least once in the past month? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Calibration_Day
	PX810401400800	If nitrogen washout method is used to more measure FRC, before use, was the accuracy of the flow and volume output measured by the device confirmed within the past 24 hours with a calibrating syringe? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Calibration_Zero
	PX810401400600	If nitrogen washout method is used to more measure FRC, was the N2 analyzer tared to zero using 100% O2 and then exposed to room air to confirm calibration? The percentage of N2 for room air should be within 0.5% of the expected reading for room air show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Measurement_Technique
	PX810401400500	If nitrogen washout method is used to more measure FRC, does the measurement technique adhere to the following steps? 1) Equipment is turned on and allowed an adequate warm-up time, with calibration as instructed by manufacturer; 2) Patient should be aske show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Quality_Control
	PX810401400100	If nitrogen washout method is used to more measure FRC, does the N2 analyzer have an inaccuracy <= 0.2% of full range throughout the entire measuring range (0-80%), have a resolution of <= 0.01%, and have a 95% analyzer response time of <= 60 milliseconds show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_Recalibration
	PX810401400700	If nitrogen washout method is used to more measure FRC, before initial use and once every 6 months thereafter, was the linearity of the N2 analyzer confirmed by measuring the N2 percentage of a calibration gas mixture, where the expected N2 concentration show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Nitrogen_SamplingRate
	PX810401400300	If nitrogen washout method is used to more measure FRC, for flow and nitrogen signals, does the system have a sampling rate of >= 40 samples/sec? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_Competency
	PX810401310000	For personnel directly involved in pulmonary more function testing, have they established competency in pulmonary function testing? (familiarity with theory and practical aspects of all commonly applied techniques, measurements, calibrations, hygiene, qua show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_CompetencyExam
	PX810401330000	Has personnel passed a written and practical more examination in the presence of an experienced instructor? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_FormalTraining
	PX810401300000	For personnel directly involved in pulmonary more function testing, do they have formal training emphasis in health-related sciences (such as nursing, medical assistant, respiratory therapy, etc)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_NotebookOf_Records
	PX810401350000	Are personnel maintaining a notebook of more recoreds including but not limited to: calibration procedures, test-performance procedures, calculations, criteria, reference values source, and action to be taken when 'panic' values are observed? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_Notebook_Detail
	PX810401360000	Are there detailed statements and/or more publications on the selection of references values and interpretation of lung function tests along with an assessment of the reliability of the data? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_Qualifications
	PX810401290000	Do personnel have the sufficient education more (2 years college education) and training to understand the fundamentals of the test, know the common signs of pulmonary disease, and be able to manage acquired pulmonary function data? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_RefreshTraining
	PX810401340000	If it has been more than 3 years since more his/her last competency exam or if lung function standards have been recently updated, have personnel taken a spirometry refresher training course? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Personnel_TrainingProgram
	PX810401320000	Has personnel completed training similar to more the National Institute for Occupational Safety and Health (NIOSH)-approved spirometry program? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Approach_Ic
	PX810401370306	If second method, and using the slow EVC more approach, what is the mean of technically satisfactory inspiratory capacity (IC) measurements? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Approach_Ivc
	PX810401370304	If second method, and using the IVC/ERV more approach, what is the reported value for the (technically satisfactory) inspiratory vital capacity (IVC)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Approach_Tlc
	PX810401370307	If second method, what is the calculated more value for total lung capacity (TLC)? (mean of three largest sums of technically acceptable FRC values and linked IC manuevers) show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Approach_Vc
	PX810401370303	If second method, which approach is used to more derive the value for vital capacity? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Approach_Vc
	PX810401370305	If second method, and using the IVC/ERV more approach, what is the largest measurement obtained for the vital capacity (VC)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Erv
	PX810401370302	If second method, what is the reported value more for the (technically satisfactory) expiratory reserve volume (ERV)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_SecondMethod_Frc
	PX810401370301	If second method, what is the reported value more for the functional residual capacity (mean of technically satisfactory FRC measurements)? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Spirometer_Recalibration
	PX810401260000	If the spirometer was disassembled and more cleaned, was the device re-calibrated? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subjects_Infected_Precautions
	PX810401270000	For subjects with transmissible infectious more diseases, were any of the following precautions taken? Reserving equipment for the sole purpose of testing infected patients, testing such patients at the end of the day to allow time for spirometer disassem show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_AbilityTo_Cooperate
	PX810401200000	Does the subject show signs of limited more ability to cooperate? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Activities
	PX810401040000	Was the subject involved in any of the more following activities? Smoke within at least 1 hour of testing, consuming alcohol within 4 hours of testing, performing vigorous exercise within 30 minutes of testing, wearing clothing that substantially restrict show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Age
	PX810401060000	What is the subject's age?	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_Subject_Arm_Span
	PX810401080200	If so, what is the subject's arm span from more fingertip to fingertip? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Bmi
	PX810401110000	What is the subject's body mass index?	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_Subject_Conditions
	PX810401030000	Does the subject suffer from any of the more following conditions: chest or abdominal pain of any cause, oral or facial pain exacerbated by a mouthpiece, stress incontinence, dementia or confusional state? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Denture
	PX810401130000	Does the subject wear any denture or dental more treatments that are loose and/or that may interfere with performance? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_DiseaseOr_Illness
	PX810401190000	Does the subject currently suffer from upper more respiratory or any other contagious disease or illness? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Height
	PX810401070000	What is the subject's height? (without more shoes, feet together) show less	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_Subject_Knee_Height
	PX810401090200	If so, what is the subject's knee height?	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Medications
	PX810401120100	Is the subject currently taking any more medication that may alter lung function? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Medications_LastTime
	PX810401120300	If so, when was the last time the drugs were more administered? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Medications_Type
	PX810401120200	If so, what type of medication is the more subject taking? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_OralSores
	PX810401210000	Does the subject suffer from open oral sores more or cuts? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_OtherHandicap
	PX810401090100	Does the subject suffer from any handicap more which prevents an accurate measurement from standing height or arm span length? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Position
	PX810401050100	Which position will the subject be in for more the duration of the test? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Position_Other
	PX810401050200	Which position will the subject be in for more the duration of the test? Other show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Repeat_EquipmentTester
	PX810401170200	If so, is the equipment and operator from more the previous session the same? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Repeat_OrderConserved
	PX810401180000	Is the planned order of lung function tests more identical to previous tests? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Repeat_TimeRestriction
	PX810401170300	If so, is the current test time within 2 more hours of the previous test time? show less	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Return_Testing
	PX810401170100	Is the subject returning for repeat testing?	N/A
PX810401_Standardisation_LungVolumeMeasurement_Subject_Thoracic_Deformity
	PX810401080100	Does the subject suffer from any deformity more of the thoracic cage, such as kyphoscoliosis? show less	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_Subject_Weight
	PX810401100000	What is the subject's weight?	Variable Mapping
PX810401_Standardisation_LungVolumeMeasurement_VC
	PX810401010000	Which of the following ways is the more measurement for vital capacity taken? show less	N/A

SCD Cardiovascular, Pulmonary, and Renal

Measure Name

Lung Function - Lung Volume

Release Date

July 30, 2015

Definition

Clinical assessment to determine the volume of gas within an individual’s lung.

Purpose

This measure can be used to differentiate obstructive and restrictive pulmonary conditions and to detect and quantify symptoms associated with conditions that impact the lung, such as sickle cell disease, cystic fibrosis, and obstructive airway disease.

Keywords

Lung function, lung volume, lung physiology, diffusion capacity, D_LCO, functional residual capacity, FRC, sickle cell disease, SCD, emphysema, Cystic fibrosis, CF, asbestosis, lupus, arthritis, smoking, sarcoidosis, carbon monoxide, obstructive airway disease, Pulmonary, asthma, sleep apnea, breathing, "Cardiovascular, Pulmonary, and Renal"

Measure Protocols

Protocol ID	Protocol Name
810401	Lung Function - Lung Volume

Publications

There are no publications listed for this protocol.

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Current_BarometricPressure

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00113392	BAROMETRIC PRESSURE (740-780 MM HG)
CARDIA Cohort	phv00114606	BAROMETRIC PRESSURE
CARDIA Cohort	phv00115701	BAROMETRIC PRESSURE
CARDIA Cohort	phv00118955	BAROMETRIC PRESSURE
Framingham Cohort	phv00022583	BAROMETRIC PRESSURE IN CENTIMETERS

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Current_Temperature

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00112468	ROOM TEMPERATURE, CENTIGRADE
CARDIA Cohort	phv00114106	ROOM TEMPERATURE IN DEGREES CENTIGRADE. Q 4
CARDIA Cohort	phv00115323	ROOM TEMPERATURE IN DEGREES CENTIGRADE. Q 4
CARDIA Cohort	phv00116546	ROOM TEMPERATURE IN DEGREES CENTIGRADE. Q 4
CARDIA Cohort	phv00118269	ROOM TEMPERATURE IN DEGREES CENTIGRADE. Q 4
CARDIA Cohort	phv00119696	ROOM TEMPERATURE IN DEGREES CENTIGRADE. Q 4
Framingham Cohort	phv00024373	ROOM TEMPERATURE (CELSIUS)
Framingham Cohort	phv00024454	ROOM TEMPERATURE (CELSIUS)
Framingham Cohort	phv00024889	ROOM TEMPERATURE (CELSIUS)
Framingham Cohort	phv00072631	Room temperature
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083441	TEMPERATURE IN CELSIUS
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087667	TEMPERATURE IN CELSIUS

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Subject_Age

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Alcohol Dependence GWAS in European- and African Americans	phv00164978	Age of participant
Asian Indian Diabetic Heart Study (AIDHS)	phv00190531	Age of participant
Autism post-mortem brain RNA-sequencing	phv00225016	Age of subject
Autosomal recessive PGM3 mutations cause a new Congenital Disorder of Glycosylation	phv00219151	Subject age
Autosomal recessive TPP2 mutations cause a new human immunodeficiency	phv00221155	Subject age
Characterization of Human Transcriptome by Computational and HTS Approaches	phv00224899	Subject age
Chromothripsis in Patient WHIM-09	phv00222544	Subject age
Ciliopathies Exome Sequencing Initiative	phv00165081	Age of subject
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00033518	Patient's age (years) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030755	Patient's age (form 001)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030341	Patient's age
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030100	Patient's age (years) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028592	Subject's age
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027984	Patient's age (form 001)
DNA Methylation Analysis of Prostate Cancer	phv00181135	Age of the subject
Drug Resistant Hypertension in African Americans' Exome	phv00164736	Age of Subject
Exome Sequencing of Esophageal Adenocarcinoma	phv00190856	Participant age
GDNF and Anxiety	phv00217717	Subject age
Genetic Measurement of Memory B-cell Recall Using Antibody Repertoire Sequencing	phv00195585	Subject age
Genetic Variation and Signatures of Natural Selection in Diverse Africans	phv00171015	Age of participant
Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Lipidomics Study	phv00202104	Age of participant
Genome-Wide Association Study of Neuroblastoma	phv00158906	Age of subject in days
Genomic Sequencing of Pediatric Rhabdoid Cancers	phv00171413	Participant age
Ghana Prostate Study	phv00226957	Subject age
HIV-1 Host Genetics Among Injection Drug Users	phv00167742	Reported age of participant
Immunosenescence: Immunity in the Young and Aged	phv00217652	Subject age
Joint Genome-Wide Gene Expression and GWAS Mapping in the MGS Dataset	phv00202327	Subject age
Melanoma Exome Sequencing	phv00226765	Subject age
Metagenomic Study of the Human Skin Microbiome Associated with Acne	phv00090398	Age of subject
NCI GWAS of Lung Cancer in Never Smokers	phv00201635	Subject age
NCI Non-Hodgkin Lymphoma GWAS	phv00225219	Subject age
NCI Non-Hodgkin Lymphoma GWAS	phv00225229	Subject age
NEI Age-Related Eye Disease Study (AREDS) - Genetic Variation in Refractive Error Substudy	phv00164694	Age of participant
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181857	Age of participant at baseline
NINDS Parkinson's Disease	phv00024004	Age of subject
NINDS Parkinson's Disease	phv00023938	Age of subject
PAGE: Epidemiologic Architecture for Genes Linked to Environment (EAGLE) - BioVU Cancer Project	phv00196393	Age of participant
POLYGEN	phv00160480	Age of participant
POPRES: Population Reference Sample	phv00066601	Age of Subject
Responses to Varicella Zoster Virus Vaccination	phv00221180	Subject age
Sensitivity to the subjective effects of amphetamine	phv00221226	Age of participant
Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes	phv00167356	Participant's age
Small Intestine Neuroendocrine Tumors (Carcinoid Tumors)	phv00190467	Participant's age [NR - not registrated]
Somatic Mutations in Variant and IGHV4-34 Expressing Hairy Cell Leukemia	phv00195930	Subject age
The Human Gut Microbiome and Recurrent Abdominal Pain in Children	phv00091113	Age of Participant
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma	phv00163063	Participant's age
The Placenta Harbors a Unique Microbiome	phv00201428	Subject Age
VESPA: Genome Wide Study of Vancomycin	phv00225884	Age of participant
Whole Exome and Transcriptome Sequencing in Sporadic ALS	phv00201704	Subject age
Whole Exome Sequencing of Diffuse Large B-Cell Lymphoma	phv00165115	Participant's age

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Subject_Bmi

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Multiethnic GWAS of Prostate Cancer	phv00142471	Body mass index (BMI)
A Multiethnic GWAS of Prostate Cancer	phv00124446	Body mass index (BMI)
Asian Indian Diabetic Heart Study (AIDHS)	phv00190532	Body Mass Index of participant
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00215389	BMI = weight/((height/100)*(height/100))
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)	phv00225194	Body mass index
Cardiovascular Health Study (CHS) Cohort	phv00110612	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00106840	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00105306	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00100386	BODY MASS INDEX (kg/m2)
Cardiovascular Health Study (CHS) Cohort	phv00099468	BODY MASS INDEX
Cardiovascular Health Study (CHS) Cohort	phv00198926	Body mass index shhs2
Cebu Longitudinal Health and Nutrition Survey (CLHNS)	phv00173308	Body mass index
Cholesterol and Pharmacogenetics (CAP) Study	phv00167793	Body mass index
CIP: Obesity-Diabetes Familial Risk	phv00191159	Subject's body mass index
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026890	Body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034524	Body mass index (kg/m**2)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00033537	Body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030764	Patient's body mass index (kg/m??)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030304	Body mass index (kg/m??)
Framingham Cohort	phv00201408	Body Mass Index
Framingham Cohort	phv00164572	Baseline BMI in kg/m2
Framingham Cohort	phv00056833	Body Mass Index (BMI = pm202/((pm207/100)*(pm207/100)))
Framingham Cohort	phv00056588	BMI = weight/((height/100)*(height/100))
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)	phv00163638	Body mass index of subject.
Geisinger eMERGE - MyCode Project	phv00163396	Body mass index of subject.
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082597	BMI
Genetic Epidemiology of COPD (COPDGene)	phv00159593	BMI
Genetic Study on Nephropathy in Type-2 Diabetes	phv00158974	Body Mass Index
GENEVA Diabetes Study (NHS/HPFS)	phv00022876	BMI in kg/m2
Genome wide association study of 24 hour urine composition in the Nurses' Health Study, Nurses' Health Study II, and the Health Professionals Follow-Up Study	phv00165553	Body mass index
Genome-Wide associations of Lung Health Study (LHS)	phv00154582	S2. Body Mass Index
Genotype-Tissue Expression (GTEx)	phv00169070	BMI
Group Health/UW Aging and Dementia eMERGE Study	phv00088219	Body_Mass_Index
Gut Microbiome Profiles and Risk of Colorectal Cancer	phv00225132	Body mass index
GWAS for Genetic Determinants of Bone Fragility	phv00065521	Body mass index
GWAS of Breast Cancer in the African Diaspora	phv00172019	Body mass index
Jackson Heart Study (JHS) Cohort	phv00165335	Baseline BMI in kg/m2
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083716	BMI
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087707	BMI
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083481	BMI
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122641	Body mass index
NIDDK Genetics of Metabolic Syndrome in an Island Population	phv00222309	BMI (kg/m2)
OPPERA baseline case-control study of chronic TMJD	phv00222759	Body Mass Index (kg/m-squared; kg/m2)
OPPERA Prospective Cohort Study of First-Onset TMJD	phv00223838	Body Mass Index (kg/m-squared)
Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study	phv00173926	Body mass index of participant, calculated from measured height and weight
POLYGEN	phv00160483	Body Mass Index of participant
Predicting Chemotherapy-Induced Mucositis with Genetic and Clinical Factors	phv00200921	Body Mass Index (kg/m**2)
Sensitivity to the subjective effects of amphetamine	phv00221233	BMI of participant
SNPs and Extent of Atherosclerosis (SEA) Study	phv00159046	BODY MASS INDEX
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129627	Body mass index
The Cardiopulmonary Effects of Particulate Exposure	phv00252415	Subect's body mass index
The Finland-United States Investigation of NIDDM Genetics (FUSION) Study	phv00222668	Body mass index
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066355	Body Mass Index
Type 2 Diabetes in African Americans, GWAS and Exome Sequencing	phv00066341	Body Mass Index
Type 2 Diabetes Starr County GWAS and Exome Sequencing	phv00066509	Body mass index (BMI)
Whole Genome Association Study of Visceral Adiposity in the HABC Study	phv00071834	Body Mass Index
Whole-Genome and Exome Sequencing in Clear-Cell Renal Cell Carcinoma	phv00168013	Body Mass Index
Women's Health Initiative	phv00079867	BMI

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Subject_Height

dbGAP Study	dbGAP Variable	dbGAP Variable Description
CARDIA Cohort	phv00116480	PATIENT DATA: HEIGHT (CM)
Columbia University Study of Caribbean Hispanics and Late Onset Alzheimer's disease	phv00180593	Height of subject
CPTAC Proteogenomic Confirmatory Study	phv00225400	Provide the height of the participant in centimeters.
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00029374	Patient's height
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034113	Patient's height (cm)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030689	Patient's height (cm) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030103	Patient's height (cm) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027262	Patient's height
eMERGE Genome-Wide Association Studies of Obesity	phv00163599	Height of subject.
eMERGE Genome-Wide Association Studies of Obesity (Metabochip)	phv00163770	Height of subject.
Genetic Variation and Signatures of Natural Selection in Diverse Africans	phv00171914	Height of participant
Genomic Wide Scans for Female Osteoporosis Genes	phv00161536	Height of study subject.
Jackson Heart Study (JHS) Cohort	phv00181213	Standing height in centimeters at first participant visit
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181864	Height of participant at baseline
POLYGEN	phv00160481	Height of participant
Sensitivity to the subjective effects of amphetamine	phv00221231	Height of participant
Sequencing of Targeted Genomic Regions Associated with Smoking	phv00217970	Participant height in inches
The CARDIA-GENEVA Study	phv00129521	Participant's height, CM at Exam 1

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Subject_Thoracic_Deformity

dbGAP Study	dbGAP Variable	dbGAP Variable Description
Framingham Cohort	phv00000500	CHEST EXAMINATION: DEFORMITY, EXAM 1

Mapping for PX810401_Standardisation_LungVolumeMeasurement_Subject_Weight

dbGAP Study	dbGAP Variable	dbGAP Variable Description
A Genome-Wide Association Study in Breast Cancer Patients from the SUCCESS Trial	phv00174067	Weight (to calculate BMI)
A Genome-Wide Association Study of Peripheral Arterial Disease	phv00076115	Subject's weight at enrollment
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091446	WEIGHT TO THE NEAREST LB Q4
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091466	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00091479	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092562	WEIGHT TO NEAREST LB Q1
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092574	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00092584	WEIGHT TO NEAREST LB Q2
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00093440	WEIGHT 4
Atherosclerosis Risk in Communities (ARIC) Cohort	phv00097917	WEIGHT TO THE NEAREST LB Q4
CARDIA Cohort	phv00114073	WEIGHT - MON 12
CARDIA Cohort	phv00114831	SUBJECT'S WEIGHT IN POUNDS. Q 3
CARDIA Cohort	phv00115857	SUBJECT'S WEIGHT (LBS). Q 2
CARDIA Cohort	phv00117231	SUBJECT'S WEIGHT (LBS). Q 2a
CARDIA Cohort	phv00117926	WEIGHT - MON 96
CARDIA Cohort	phv00118137	WEIGHT
CARDIA Cohort	phv00118251	WEIGHT
CARDIA Cohort	phv00119094	SUBJECT'S WEIGHT (LBS). Q 2a
CARDIA Cohort	phv00119573	WEIGHT (LBS) - FORM 53
CARDIA Cohort	phv00120996	SUBJECT'S WEIGHT (LBS). Q 2a
Cardiovascular Health Study (CHS) Cohort	phv00098848	WEIGHT (lb)
Cardiovascular Health Study (CHS) Cohort	phv00099349	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00100383	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00101789	WEIGHT IN POUNDS
Cardiovascular Health Study (CHS) Cohort	phv00102454	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00104028	WEIGHT IN POUNDS AT YEAR 3 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00104759	WEIGHT IN POUNDS
Cardiovascular Health Study (CHS) Cohort	phv00105147	WEIGHT
Cardiovascular Health Study (CHS) Cohort	phv00105414	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00106776	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00107778	WEIGHT IN POUNDS AT YEAR 6 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00108569	WEIGHT IN POUNDS AT YEAR 7 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00109512	WEIGHT IN POUNDS AT YEAR 8 VISIT
Cardiovascular Health Study (CHS) Cohort	phv00110376	WEIGHT - LBS
Cardiovascular Health Study (CHS) Cohort	phv00198931	2 weight in kg (multiply by 10)
Cardiovascular Health Study (CHS) Cohort	phv00197432	Weight in kilograms
CCDG: Dental Caries and CL/P in Guatemala	phv00164777	Weight in kilograms.
Cebu Longitudinal Health and Nutrition Survey (CLHNS)	phv00173310	Weight
Chronic Renal Insufficiency Cohort Study (CRIC)	phv00173256	Weight (kg)
CIP: Obesity-Diabetes Familial Risk	phv00191157	Subject's weight
Columbia University Study of Caribbean Hispanics and Late Onset Alzheimer's disease	phv00180594	Weight of subject
CPMCRI Breast Health Cohort	phv00162745	Participant's weight
CPTAC Proteogenomic Confirmatory Study	phv00225399	Provide the weight of the participant measured in kilograms.
Cutaneous Microbiome in Psoriasis (HMP Demonstration Study)	phv00196073	Subject's weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00025689	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026032	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026033	Current height
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026469	CBL00: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00026683	CBL6: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027263	Patient's weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027317	CBL1: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027384	CBL2: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027428	Body weight (kg): baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027431	Body weight (kg): quarterly visit 01
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027434	Body weight (kg): quarterly visit 02
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027437	Body weight (kg): quarterly visit 03
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027444	Body weight (kg): quarterly visit 04
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027447	Body weight (kg): quarterly visit 05
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027450	Body weight (kg): quarterly visit 06
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027453	Body weight (kg): quarterly visit 07
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027460	Body weight (kg): quarterly visit 08
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027463	Body weight (kg): quarterly visit 09
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027466	Body weight (kg): quarterly visit 10
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027469	Body weight (kg): quarterly visit 11
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027476	Body weight (kg): quarterly visit 12
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027479	Body weight (kg): quarterly visit 13
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027482	Body weight (kg): quarterly visit 14
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027485	Body weight (kg): quarterly visit 15
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027492	Body weight (kg): quarterly visit 16
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027495	Body weight (kg): quarterly visit 17
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027498	Body weight (kg): quarterly visit 18
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027501	Body weight (kg): quarterly visit 19
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027508	Body weight (kg): quarterly visit 20
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027511	Body weight (kg): quarterly visit 21
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027514	Body weight (kg): quarterly visit 22
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027517	Body weight (kg): quarterly visit 23
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027524	Body weight (kg): quarterly visit 24
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027527	Body weight (kg): quarterly visit 25
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027530	Body weight (kg): quarterly visit 26
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027533	Body weight (kg): quarterly visit 27
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027540	Body weight (kg): quarterly visit 28
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027543	Body weight (kg): quarterly visit 29
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027546	Body weight (kg): quarterly visit 30
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027549	Body weight (kg): quarterly visit 31
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027556	Body weight (kg): quarterly visit 32
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027559	Body weight (kg): quarterly visit 33
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027562	Body weight (kg): quarterly visit 34
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027565	Body weight (kg): quarterly visit 35
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027572	Body weight (kg): quarterly visit 36
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00027575	Body weight (kg): close-out
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028551	CBL7: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028927	Current weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00028929	Patient's desired weight
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00029760	Patient's current weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030104	Patient's weight (kg) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030409	CBL3: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030611	Weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030612	Weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030613	Weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030614	Weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00030688	Patient's weight (kg) at baseline
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031025	CBL9: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031092	CBL8: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031247	Current weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031598	CBL4: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00031756	CBL5: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00032580	CBL10: Renal test - 18: patient's weight in kg
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034114	Patient's weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00034523	Weight (kg)
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048913	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048914	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048915	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00048916	Q1d. Physical examination, weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049331	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049332	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049333	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00049334	Q1d. Physical examination, weight: 4th measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065872	Q1a. Physical examination, weight: 1st measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065873	Q1b. Physical examination, weight: 2nd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065874	Q1c. Physical examination, weight: 3rd measurement
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes	phv00065875	Q1d. Physical examination, weight: 4th measurement
Dental Caries GWAS	phv00090202	Weight in kilograms (kg)
Dental Caries GWAS	phv00165475	Weight in kilograms
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090694	Average weight, in kilograms
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090712	Weight - a
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090713	Weight - b
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090714	Weight - c
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090715	Weight - avg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090806	Weight a - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090807	Weight a - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090808	Weight a - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090809	Weight b - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090810	Weight b - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090811	Weight b - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090812	Weight c - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090813	Weight c - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090814	Weight c - kg
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090815	Weight d (Average) - lbs
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090816	Weight d (Average) - oz
Diet, Genetic Factors, and the Gut Microbiome in Crohn's Disease	phv00090817	Weight d (Average) - kg
eMERGE Genome-Wide Association Studies of Obesity (Metabochip)	phv00163771	Weight prior to bariatric surgery.
eMERGE Network Combined Dataset	phv00182436	Subject's weight at enrollment
FaceBase Study of Facial Shape in Tanzania: CIDR	phv00202482	Weight in kg
Familial Exome Sequencing in Rare Pediatric Phenotypes	phv00179542	Subject's weight
Family Investigation of Nephropathy and Diabetes (FIND) Study	phv00161442	Weight at enrollment
Framingham Cohort	phv00177537	Anthropometry: Weight
Framingham Cohort	phv00164574	Weight in kg. at baseline
Framingham Cohort	phv00000541	WEIGHT, EXAM 1
Framingham Cohort	phv00000552	MEDIAN WEIGHT
Framingham Cohort	phv00000632	WEIGHT, EXAM 2
Framingham Cohort	phv00000646	WEIGHT, EXAM 3
Framingham Cohort	phv00000679	WEIGHT, EXAM 4
Framingham Cohort	phv00000746	WEIGHT, EXAM 5
Framingham Cohort	phv00000829	WEIGHT, EXAM 6
Framingham Cohort	phv00000915	WEIGHT, EXAM 7
Framingham Cohort	phv00001037	WEIGHT (WHOLE POUNDS)
Framingham Cohort	phv00001189	BODY WEIGHT
Framingham Cohort	phv00001366	BODY WEIGHT
Framingham Cohort	phv00001563	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00001807	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002022	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002206	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002427	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00002670	BODY WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003244	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003302	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00003668	WEIGHT
Framingham Cohort	phv00004084	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00004526	WEIGHT (POUNDS, TO NEAREST POUND)
Framingham Cohort	phv00005541	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00005921	WEIGHT (TO NEAREST POUND, WITHOUT SHOES AND IN LIGHT CLOTHES)
Framingham Cohort	phv00006033	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00006328	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00006671	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00007098	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00007569	BODY WEIGHT
Framingham Cohort	phv00007676	BODY WEIGHT (KG)
Framingham Cohort	phv00007678	BODY WEIGHT (LB)
Framingham Cohort	phv00008713	WEIGHT IN POUNDS
Framingham Cohort	phv00009100	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00009552	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00010108	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00010498	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00021229	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00055259	Weight in kilograms
Framingham Cohort	phv00055291	Weight in kilograms
Framingham Cohort	phv00056838	Weight in kilograms
Framingham Cohort	phv00070552	WEIGHT (TO NEAREST POUND)
Framingham Cohort	phv00072335	WEIGHT (TO NEAREST POUND)
GAW16 Framingham and Simulated Data	phv00051739	WEIGHT IN POUNDS EXAM 1
GAW16 Framingham and Simulated Data	phv00051740	WEIGHT IN POUNDS EXAM 4
GAW16 Framingham and Simulated Data	phv00051741	WEIGHT IN POUNDS EXAM 7
GAW16 Framingham and Simulated Data	phv00051742	WEIGHT IN POUNDS EXAM 11
GAW16 Framingham and Simulated Data	phv00051807	WEIGHT IN POUNDS EXAM 1
GAW16 Framingham and Simulated Data	phv00051808	WEIGHT IN POUNDS EXAM 3
GAW16 Framingham and Simulated Data	phv00051809	WEIGHT IN POUNDS EXAM 5
GAW16 Framingham and Simulated Data	phv00051810	WEIGHT IN POUNDS EXAM 7
GAW16 Framingham and Simulated Data	phv00051848	WEIGHT IN POUNDS EXAM 1
Geisinger eMERGE - Abdominal Aortic Aneurysm Project (AAAP)	phv00163636	Current weight of subject.
Geisinger eMERGE - MyCode Project	phv00163394	Current weight of subject.
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082611	Weight
GenADA/LONG/Imaging (Genetic Alzheimer's Disease Associations)	phv00082613	Weight Units
Genes and Blood Clotting Study (GABC)	phv00124353	Participant weight at time of registration
Genetic Epidemiology of COPD (COPDGene)	phv00159591	Weight [kg]
Genetic Factors Linked with Renal Disease Progression (PediGFR) - CKiD	phv00195603	Average Weight
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073450	Weight
Genetic Multiple Sclerosis Associations - GeneMSA	phv00073451	Weight - units
GENEVA Diabetes Study (NHS/HPFS)	phv00076250	Weight in kg at time of blood draw
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00022827	Weight to the nearest lb at visit 1
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080697	Weight to the nearest lb at visit 2
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080709	Weight to the nearest lb at visit 3
GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study	phv00080719	Weight to nearest lb at visit 4
Genome-Wide Association Study of Schizophrenia	phv00020423	Please enter below your current weight in pounds:
Genome-Wide Association Study of Schizophrenia	phv00034789	Please enter below your current weight in pounds:
Genomic Wide Scans for Female Osteoporosis Genes	phv00161537	Weight of study subject.
Genotype-Tissue Expression (GTEx)	phv00169069	Weight Units (Demography)
Genotype-Tissue Expression (GTEx)	phv00169068	Weight (Demography)
Group Health/UW Aging and Dementia eMERGE Study	phv00088221	Weight
GWAS for Genetic Determinants of Bone Fragility	phv00065520	Weight at primary study visit
GWAS of Breast Cancer in the African Diaspora	phv00172018	Body weight
GWAS on Cataract and HDL in the PMRP	phv00181815	How much {do you/does the participant} weigh without clothes or shoes? [If {you are/she is} currently pregnant, how much did {you/she} weigh before your pregnancy?]
GWAS on Cataract and HDL in the PMRP	phv00073576	Subject's weight at enrollment
HAPO Maternal Glycemia and Birthweight GEI Study	phv00098541	Mother's pre-pregnancy weight
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158675	Weight in pounds
HMP Core Microbiome Sampling Protocol A (HMP-A)	phv00158676	Weight in kilograms
Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia	phv00161489	Subject weight
Jackson Heart Study (JHS) Cohort	phv00125861	A. Height and weight. 2: Weight to nearest kilogram [Visit 1]
Jackson Heart Study (JHS) Cohort	phv00181211	Weight in kilograms at first participant visit
Jackson Heart Study (JHS) Cohort	phv00165337	Weight in kilograms at baseline
Location and Function of Cytosine-5 Methylation in RNA	phv00226199	Subject's weight
Molecular Genetics of Schizophrenia - nonGAIN Sample (MGS_nonGAIN)	phv00071649	Please enter below your current weight in pounds:
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00082685	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083472	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00083707	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00084484	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00085800	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086299	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00086752	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087079	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00087698	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176168	WEIGHT AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176060	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00176055	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00175859	WEIGHT (lbs)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174745	WEIGHT AT CT
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174637	BODY COMPOSITION SCALE: CURRENT BODY WEIGHT (kg)
Multi-Ethnic Study of Atherosclerosis (MESA) Cohort	phv00174632	WEIGHT (lbs)
NEIGHBOR Consortium Glaucoma GWAS	phv00129668	Weight at enrollment (lbs) 999: Missing
Neurodevelopmental Genomics: Trajectories of Complex Phenotypes	phv00194236	Medical: Weight: lb
NHGRI Genome-Wide Association Study of Venous Thromboembolism (GWAS of VTE)	phv00121873	Weight at current appt date
NHLBI ARIC Candidate Gene Association Resource (CARe)	phv00190307	Weight in kg. at first participant visit
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00123776	Weight (kg)
NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe)	phv00122639	Weight in kilograms
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC)	phv00163953	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CARDIA)	phv00190565	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS)	phv00165170	Weight in kg. at baseline
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ISGS)	phv00179602	Weight in kg
NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (MESA)	phv00178036	Weight in kg at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Asthma)	phv00181865	Weight of participant at baseline
NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease)	phv00160352	ESP, weight in lbs. at baseline
NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP	phv00165268	BASELINE WEIGHT IN KG
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200563	Prepregnancy weight (lbs)
NICHD Genomic and Proteomic Network for Preterm Birth Research (GPN)	phv00200564	Weight (in lbs)
PAGE: Multiethnic Cohort (MEC)	phv00163105	Weight (kg) reported at baseline
Pediatric Cardiac Genetics Consortium (PCGC)	phv00180764	Weight in kilograms
PediGFR - 4C Study Cohort	phv00221103	Weight
PediGFR - ESCAPE Trial Cohort	phv00221126	Weight
PGRN Antidepressant Medication Pharmacogenomic Study (AMPS)	phv00195999	Baseline Weight
PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events Study	phv00076277	Weight
PGRN-RIKEN NSABP Prevention Study	phv00124506	Weight
POLYGEN	phv00160482	Weight of participant
Sensitivity to the subjective effects of amphetamine	phv00221232	Weight of participant
Sequencing of Targeted Genomic Regions Associated with Smoking	phv00217971	Participant weight in pounds
Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency	phv00090683	Subject's weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00070941	Baseline weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071001	Weight at follow-up visit
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071052	Baseline Weight
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071109	Weight at follow-up (kg)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071160	Baseline weight (kg)
SNP Health Association Resource (SHARe) Asthma Resource Project (SHARP)	phv00071217	Weight at follow-up (kg)
STAMPEED: Northern Finland Birth Cohort 1966 (NFBC1966)	phv00129622	Weight
Study of Addiction: Genetics and Environment (SAGE)	phv00022913	Participant's weight in pounds
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171725	Weight at the fifth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171722	Weight at the second study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171724	Weight at the fourth study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171723	Weight at the third study visit
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171720	Weight at the most recent study visit for which we have data for this participant
T2D-GENES: San Antonio Mexican American Family Studies (SAMAFS)	phv00171721	Weight at the first study visit
The CARDIA-GENEVA Study	phv00129531	Subject's weight [in LBS] at Exam 5
The CARDIA-GENEVA Study	phv00129533	Subject's weight [in LBS] at Exam 6
The CARDIA-GENEVA Study	phv00129535	Subject's weight [in LBS] at Exam 7
The CARDIA-GENEVA Study	phv00129529	Subject's weight [in LBS] at Exam 4
The CARDIA-GENEVA Study	phv00129527	Subjects weight [in LBS] at Exam 3
The CARDIA-GENEVA Study	phv00129525	Subjects weight in pounds at Exam 2
The CARDIA-GENEVA Study	phv00129522	Participant's weight [in LBS] at Exam 1
The Cardiopulmonary Effects of Particulate Exposure	phv00252413	Subject's weight
The Effect of the Menstrual Cycle on the Normal Human Breast	phv00193892	Weight in pounds
The Genetic Architecture of Smoking and Smoking Cessation	phv00162809	Participant's weight in pounds
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180536	Weight (pounds)
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00180469	Weight of participant (lbs)
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial	phv00179643	Weight (pounds)
The Human Virome and Febrile Illness in Children	phv00098426	Weight of the participant during collection of sample
The Sea Islands Genetic Network (SIGNET)	phv00163537	Weight at enrollment
University of Miami Study on Genetics of Autism and Related Disorders (AutismDisorders)	phv00171542	Subject's weight
Whole Genome Association Study of Bipolar Disorder	phv00035240	Please enter below your current weight in pounds. (Participants with European ancestry)
Whole Genome Association Study of Bipolar Disorder	phv00054548	Please enter below your current weight in pounds. (African American participants)
Whole-Genome Sequencing of Acute Myeloid Leukemia	phv00073673	Subject's weight in kilograms
Women's Health Initiative	phv00077673	Current weight lbs
Women's Health Initiative	phv00077799	Current weight lbs
Women's Health Initiative	phv00077909	Current weight lbs
Women's Health Initiative	phv00078111	Current weight lbs
Women's Health Initiative	phv00078235	Current weight lbs
Women's Health Initiative	phv00079558	Current weight, lbs
Women's Health Initiative	phv00079859	F80 Weight kg